Complete protection from low-dose streptozotocin-induced diabetes in mice.
D000818:Animals; D000961:Antilymphocyte Serum / Q000627:therapeutic use; D001786:Blood Glucose / Q000378:metabolism; D003921:Diabetes Mellitus, Experimental / Q000517:prevention & control*; D005951:Glucose Tolerance Test; D007515:Islets of Langerhans / Q000187:drug effects; D008757:Methylglucosides / Q000494:pharmacology; D051379:Mice; D010195:Pancreatitis / Q000139:chemically induced / Q000628:therapy; D013311:Streptozocin / Q000008:administration & dosage / Q000037:antagonists & inhibitors*
D000961:Antilymphocyte Serum; D001786:Blood Glucose; D008757:Methylglucosides; D013311:Streptozocin